Search results for "PD"

showing 10 items of 1971 documents

Pharmacological Management of Elderly Patients with Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome: Room for Speculation?

2016

Asthma and chronic obstructive pulmonary disease (COPD) are two distinct diseases that share a condition of chronic inflammation of the airways and bronchial obstruction. In clinical settings, it is not rare to come across patients who present with clinical and functional features of both diseases, posing a diagnostic dilemma. The overlap condition has been termed asthma–COPD overlap syndrome (ACOS), and mainly occurs in individuals with long-standing asthma, especially if they are also current or former smokers. Patients with ACOS have poorer health-related quality of life and a higher exacerbation rate than subjects with asthma or COPD alone. Whether ACOS is a distinct nosological entity …

medicine.medical_specialtyExacerbationPopulationSettore MED/10 - Malattie Dell'Apparato RespiratorioPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicinePharmacotherapyAdrenal Cortex HormonesAdministration InhalationPrevalencemedicineHumansPharmacology (medical)030212 general & internal medicineIntensive care medicineeducationAgedAsthmaCOPDeducation.field_of_studyLungbusiness.industryOverlap syndromemedicine.diseaseAsthmaBronchodilator Agentsrespiratory tract diseasesmedicine.anatomical_structure030228 respiratory systemQuality of LifePhysical therapyDrug Therapy CombinationSalmeterolGeriatrics and Gerontologybusinessmedicine.drugDrugs & Aging
researchProduct

Determinants of Sleepiness at Wheel and Missing Accidents in Patients With Obstructive Sleep Apnea

2021

Study ObjectivesMotor-vehicle crashes are frequent in untreated OSA patients but there is still uncertainty on prevalence as well as physiological or clinical determinants of sleepiness at the wheel (SW) in OSA patients. We assessed determinants of SW or sleepiness related near-miss car accident (NMA) in a group of non-professional drivers with OSA.MethodsA 237 consecutive, treatment-naïve PSG-diagnosed OSA patients (161 males, 53.1 ± 12.6 years) were enrolled. Self-reported SW was assessed by positive answer to the question, “Have you had episodes of falling asleep while driving or episodes of drowsiness at wheel that could interfere with your driving skill in the last year?” Occurrence of…

medicine.medical_specialtyExcessive daytime sleepinessexcessive daytime sleepinelcsh:RC321-571OSAInternal medicinemedicineCOPDIn patientsleepiness at wheellcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal ResearchCOPDbusiness.industryGeneral NeuroscienceEpworth Sleepiness Scaleexcessive daytime sleepinessSleep apneamedicine.diseasesleep apneaSleep timeObstructive sleep apneamedicine.symptombusinessSleep durationNeuroscience
researchProduct

Inspiratory muscle training combined with pursed lip technique in women with chronic osbtructive pulmonary disease: a case study.

2020

Objective. To improve pulmonary function, exercise capacity and quality of life of two women with Chronic Obstructive Pulmonary Disease (COPD). Material and Methods. Study of two clinical cases, both women. An intervention of 8 weeks was performed, in which the patients performed 3 weekly sessions, of which 1 was performed with supervision of the physiotherapist and 2 sessions were performed at home. The treatment sessions consisted of inspiratory muscle training with an inspiratory threshold and controlled breathing exercises with the pursed lip technique. Results. Quality of life of both women improved at the end of the study. In the woman with severe COPD, Maximal Inspiratory Pressure (M…

medicine.medical_specialtyFisioteràpiaAerospace EngineeringPulmonary diseaseSevere copdchronic obstructive pulmonary diseasePulmonary function testinglcsh:GV557-1198.995Quality of lifeMedicinelcsh:Sports medicinepursed liplcsh:SportsCOPDinspiratory muscle trainingControlled breathingbusiness.industryInspiratory muscle trainingExercise capacitymedicine.diseaserespiratory tract diseasesrespiratory physiotherapyPhysical therapylcsh:RC1200-1245businessPulmons Malalties
researchProduct

Inhibition of ovarian steroidogenesis by cyclic-GMP in a fly

2003

1479-6805 0022-0795; Previous investigations in the female blowfly Phormia regina have shown that 3-isobutyl-1-methylxanthine (IBMX), a broad spectrum inhibitor of phosphodiesterases (PDEs), fails to mimic the steroidogenic effects of cAMP on ovaries, although it efficiently increases the concentrations of this second messenger. In this study, experiments carried out to clear up this contradiction demonstrated that IBMX, besides its effect on cAMP, also increased cGMP concentrations in blowfly ovary and that these two cyclic nucleotides controlled ovarian steroidogenesis antagonistically. In particular, a selective inhibitor of cGMP-specific PDEs, unlike IBMX, had a very strong negative eff…

medicine.medical_specialtyIBMXIndolesPhosphodiesterase InhibitorsEndocrinology Diabetes and MetabolismCarbazolesOvarySteroid biosynthesisBiologychemistry.chemical_compoundEndocrinologyAlkaloidsOrgan Culture TechniquesInternal medicine1-Methyl-3-isobutylxanthinemedicineCyclic AMPCyclic GMP-Dependent Protein KinasesAnimalsAutocrine signallingCyclic GMPAdenineDipteraColforsinOvaryPhosphodiesteraseBrainEcdysteroidsStimulation ChemicalEndocrinologymedicine.anatomical_structurechemistrySecond messenger systemQuinazolinesFemalePDE10ACalcium ChannelscGMP-dependent protein kinaseSignal Transduction
researchProduct

The phototransduction cascade in the isolated chick pineal gland revisited.

2003

It is well established that the isolated chick pineal gland is directly light sensitive and that melatonin synthesis of the gland can be inhibited by exposing the gland to light during scotophase. Since not all the steps of the phototransduction cascade have been clarified to the same extent as in the retina, we have treated isolated chick pineal glands with 90 min of light during scotophase and with drugs that affect key-components of vertebrate phototransduction, i.e., cyclic guanosine monophosphate (cGMP) phosphodiesterase 6 (PDE6), cGMP levels and cGMP-gated calcium channels. The endpoint measured was the activity of the rate-limiting enzyme of melatonin synthesis, arylalkylamine N-acet…

medicine.medical_specialtyLight Signal TransductionArylamine N-AcetyltransferasePhosphodiesterase 3BiologyNitric OxidePineal GlandRetinachemistry.chemical_compoundPineal glandOrgan Culture TechniquesInternal medicinemedicineCyclic AMPAnimalsCyclic adenosine monophosphateNitric Oxide DonorsEnzyme InhibitorsMolecular BiologyCyclic guanosine monophosphateCyclic GMPMelatoninCyclic Nucleotide Phosphodiesterases Type 6Phosphoric Diester HydrolasesGeneral NeurosciencePhosphodiesteraseNatriuretic Peptide C-TypeCyclic Nucleotide Phosphodiesterases Type 3Circadian RhythmCalcium Channel Agonistsmedicine.anatomical_structureEndocrinologychemistry3'5'-Cyclic-AMP PhosphodiesterasesNeurology (clinical)PDE10ACalcium ChannelsZaprinastChickensPhotic StimulationDevelopmental BiologyEndocrine glandBrain research
researchProduct

Patterns and Predictors of Recovery from Poor Health Status Measured with the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test in Patient…

2019

Recent recommendations for chronic obstructive pulmonary disease (COPD) suggest that evaluation and management should focus on patient health status. Despite the frequency of poor health status and its negative impact on patients with COPD, little is known about how poor or non-poor health status persists and/or remits over time or what factors might predict recovery from a poor health status. The aim was to determine the likelihood of transitioning between poor and non-poor health status in patients with stable COPD followed for 2 years and to investigate factors that might predict recovery from poor health status. We prospectively included 137 patients with stable COPD (mean age, 66.9 yea…

medicine.medical_specialtyLongitudinal studyPulmonary diseaselcsh:Medicinehealth statusnon-smokerArticle03 medical and health sciencesrecovery0302 clinical medicineInternal medicinemedicineCOPDIn patient030212 general & internal medicineGeneralized estimating equationLungs -- DiseasesCOPDhandgrip strengthbusiness.industrylcsh:RPulmons -- MalaltiesCATGeneral MedicineOdds ratiomedicine.diseaseConfidence interval030228 respiratory systemCopd assessment testbusinesstransitionsJournal of Clinical Medicine
researchProduct

Molecular typing of Candida albicans isolates from patients and health care workers in a neonatal intensive care unit

2011

Aims:  The aim of this study was to investigate the genetic relatedness between Candida albicans isolates and to assess their nosocomial origin and the likeliness of cross-transmission between health care workers (HCWs) and hospitalized neonates in a neonatal intensive care unit (NICU). Methods:  We retrospectively analysed 82 isolates obtained from 40 neonates and seven isolates from onychomycosis of the fingers of five HCWs in a Tunisian NICU by using pulsed-field gel electrophoresis (PFGE) and randomly amplified polymorphic DNA (RAPD) analysis with CA1 and CA2 as primers. Results:  In RAPD analysis, the discriminatory power (DP) of CA1 and CA2 primers was 0·86 and 0·81, respectively. A h…

medicine.medical_specialtyNeonatal intensive care unitbiologyIncidence (epidemiology)Fungal geneticsGeneral Medicinebiology.organism_classificationApplied Microbiology and BiotechnologyMycological Typing TechniquesMicrobiologyRAPDInternal medicineGenotypemedicinePulsed-field gel electrophoresisCandida albicansBiotechnologyJournal of Applied Microbiology
researchProduct

Mepolizumab for eosinophilic chronic obstructive pulmonary disease

2017

BACKGROUNDPatients with chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype may benefit from treatment with mepolizumab, a monoclonal antibody directed against interleukin-5.METHODSWe performed two phase 3, randomized, placebo-controlled, double-blind, parallel-group trials comparing mepolizumab (100 mg in METREX, 100 or 300 mg in METREO) with placebo, given as a subcutaneous injection every 4 weeks for 52 weeks in patients with COPD who had a history of moderate or severe exacerbations while taking inhaled glucocorticoid-based triple maintenance therapy. In METREX, unselected patients in the modified intention-to-treat population with an eosinophilic phenotype were …

medicine.medical_specialtyPARALLEL-GROUPPopulationPlacebo-controlled studyPNEUMONIA RISKPlaceboPLACEBO-CONTROLLED TRIALGastroenterology03 medical and health sciencesDOUBLE-BLIND0302 clinical medicineMaintenance therapyInternal medicineEosinophilicmedicineINHALED FLUTICASONE FUROATE030212 general & internal medicineeducationCOPDeducation.field_of_studyIntention-to-treat analysisCOPD ASSESSMENT TESTSPUTUM EOSINOPHILIAbusiness.industryGeneral MedicineRANDOMIZED CONTROLLED-TRIALBLOOD EOSINOPHILSmedicine.diseaseSECONDARY ANALYSIS030228 respiratory systemImmunologybusinessMepolizumabmedicine.drug
researchProduct

Advanced technologies for detecting tremor in Parkinson's disease.

2019

Objective Accurate and reliable detection of tremor onset in Parkinson’s disease (PD) is critical to the success of adaptive deep brain stimulation (aDBS) therapy. Here, we investigated the potential use of feature engineering and machine learning methods for more accurate detection of rest tremor in PD. Methods We analyzed the local field potential (LFP) recordings from the subthalamic nucleus region in 12 patients with PD (16 recordings). To explore the optimal biomarkers and the best performing classifier, the performance of state-of-the-art machine learning (ML) algorithms and various features of the subthalamic LFPs were compared. We further used a Kalman filtering technique in feature…

medicine.medical_specialtyParkinson's diseaseEssential TremorRestMEDLINEAdaptive deep-brain stimulationArticlePhysical medicine and rehabilitationPhysiology (medical)TremormedicineHumansRest (music)Essential tremorbusiness.industryParkinson DiseaseMachine learning (ML)medicine.diseaseParkinson’s disease (PD)Sensory SystemsTremor detectionNeurologyLocal field potential (LFP)Neurology (clinical)businessKalman filteringClinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
researchProduct

Fusion of the 1H NMR data of serum, urine and exhaled breath condensate in order to discriminate chronic obstructive pulmonary disease and obstructiv…

2015

Chronic obstructive pulmonary disease, COPD, affects the condition of the entire human organism and causes multiple comorbidities. Pathological lung changes lead to quantitative changes in the composition of the metabolites in different body fluids. The obstructive sleep apnea syndrome, OSAS, occurs in conjunction with chronic obstructive pulmonary disease in about 10–20 % of individuals who have COPD. Both conditions share the same comorbidities and this makes differentiating them difficult. The aim of this study was to investigate whether it is possible to diagnose a patient with either COPD or the OSA syndrome using a set of selected metabolites and to determine whether the metabolites t…

medicine.medical_specialtyPathology(COPD)Endocrinology Diabetes and MetabolismMetaboliteClinical BiochemistryChronic obstructive pulmonary disease (COPD)Urinediscriminant modelsBiochemistryGastroenterologychronic obstructive pulmonary diseasechemistry.chemical_compoundNMR spectroscopyInternal medicinePartial least squares regressionMedicineExhaled breath condensatePathologicalCOPDLungbusiness.industrymedicine.diseasechemometricsrespiratory tract diseasesObstructive sleep apneamedicine.anatomical_structurechemistrybusinessobstructive sleep apnea syndrome (OSAS)Metabolomics
researchProduct